Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer

Tateaki Naito, Shuichi Mitsunaga, Satoru Miura, Noriatsu Tatematsu, Toshimi Inano, Takako Mouri, Tetsuya Tsuji, Takashi Higashiguchi, Akio Inui, Taro Okayama, Teiko Yamaguchi, Ayumu Morikawa, Naoharu Mori, Toshiaki Takahashi, Florian Strasser, Katsuhiro Omae, Keita Mori, Koichi Takayama

研究成果: Article

10 引用 (Scopus)

抄録

Background: Combinations of exercise and nutritional interventions might improve the functional prognosis for cachectic cancer patients. However, high attrition and poor compliance with interventions limit their efficacy. We aimed to test the feasibility of the early induction of new multimodal interventions specific for elderly patients with advanced cancer Nutrition and Exercise Treatment for Advanced Cancer (NEXTAC) programme. Methods: This was a multicentre prospective single-arm study. We recruited 30 of 46 screened patients aged ≥70 years scheduled to receive first-line chemotherapy for newly diagnosed, advanced pancreatic, or non-small-cell lung cancer. Physical activity was measured using pedometers/accelerometer (Lifecorder ® , Suzuken Co., Ltd., Japan). An 8 week educational intervention comprised three exercise and three nutritional sessions. The exercise interventions combined home-based low-intensity resistance training and counselling to promote physical activity. Nutritional interventions included standard nutritional counselling and instruction on how to manage symptoms that interfere with patient's appetite and oral intake. Supplements rich in branched-chain amino acids (Inner Power ® , Otsuka Pharmaceutical Co., Ltd., Japan) were provided. The primary endpoint of the study was feasibility, which was defined as the proportion of patients attending ≥4 of six sessions. Secondary endpoints included compliance and safety. Results: The median patient age was 75 years (range, 70–84). Twelve patients (40%) were cachectic at baseline. Twenty-nine patients attended ≥4 of the six planned sessions (96.7%, 95% confidence interval, 83.3 to 99.4). One patient dropped out due to deteriorating health status. The median proportion of days of compliance with supplement consumption and exercise performance were 99% and 91%, respectively. Adverse events possibly related to the NEXTAC programme were observed in five patients and included muscle pain (Grade 1 in two patients), arthralgia (Grade 1 in one patient), dyspnoea on exertion (Grade 1 in one patient), and plantar aponeurositis (Grade 1 in one patient). Conclusions: The early induction of multimodal interventions showed excellent compliance and safety in elderly patients with newly diagnosed pancreatic and non-small-cell lung cancer receiving concurrent chemotherapy. We are now conducting a randomized phase II study to measure the impact of these interventions on functional prognosis.

元の言語English
ページ(範囲)73-83
ページ数11
ジャーナルJournal of Cachexia, Sarcopenia and Muscle
10
発行部数1
DOI
出版物ステータスPublished - 2019 2 1

Fingerprint

Non-Small Cell Lung Carcinoma
Exercise
Compliance
Counseling
Neoplasms
Japan
Safety
Drug Therapy
Branched Chain Amino Acids
Resistance Training
Myalgia
Arthralgia
Feasibility Studies
Appetite
Dyspnea
Health Status

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Physiology (medical)

これを引用

Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer. / Naito, Tateaki; Mitsunaga, Shuichi; Miura, Satoru; Tatematsu, Noriatsu; Inano, Toshimi; Mouri, Takako; Tsuji, Tetsuya; Higashiguchi, Takashi; Inui, Akio; Okayama, Taro; Yamaguchi, Teiko; Morikawa, Ayumu; Mori, Naoharu; Takahashi, Toshiaki; Strasser, Florian; Omae, Katsuhiro; Mori, Keita; Takayama, Koichi.

:: Journal of Cachexia, Sarcopenia and Muscle, 巻 10, 番号 1, 01.02.2019, p. 73-83.

研究成果: Article

Naito, T, Mitsunaga, S, Miura, S, Tatematsu, N, Inano, T, Mouri, T, Tsuji, T, Higashiguchi, T, Inui, A, Okayama, T, Yamaguchi, T, Morikawa, A, Mori, N, Takahashi, T, Strasser, F, Omae, K, Mori, K & Takayama, K 2019, 'Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer', Journal of Cachexia, Sarcopenia and Muscle, 巻. 10, 番号 1, pp. 73-83. https://doi.org/10.1002/jcsm.12351
Naito, Tateaki ; Mitsunaga, Shuichi ; Miura, Satoru ; Tatematsu, Noriatsu ; Inano, Toshimi ; Mouri, Takako ; Tsuji, Tetsuya ; Higashiguchi, Takashi ; Inui, Akio ; Okayama, Taro ; Yamaguchi, Teiko ; Morikawa, Ayumu ; Mori, Naoharu ; Takahashi, Toshiaki ; Strasser, Florian ; Omae, Katsuhiro ; Mori, Keita ; Takayama, Koichi. / Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer. :: Journal of Cachexia, Sarcopenia and Muscle. 2019 ; 巻 10, 番号 1. pp. 73-83.
@article{fdb4a760a14d4e1ba0ef56880fec904a,
title = "Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer",
abstract = "Background: Combinations of exercise and nutritional interventions might improve the functional prognosis for cachectic cancer patients. However, high attrition and poor compliance with interventions limit their efficacy. We aimed to test the feasibility of the early induction of new multimodal interventions specific for elderly patients with advanced cancer Nutrition and Exercise Treatment for Advanced Cancer (NEXTAC) programme. Methods: This was a multicentre prospective single-arm study. We recruited 30 of 46 screened patients aged ≥70 years scheduled to receive first-line chemotherapy for newly diagnosed, advanced pancreatic, or non-small-cell lung cancer. Physical activity was measured using pedometers/accelerometer (Lifecorder {\circledR} , Suzuken Co., Ltd., Japan). An 8 week educational intervention comprised three exercise and three nutritional sessions. The exercise interventions combined home-based low-intensity resistance training and counselling to promote physical activity. Nutritional interventions included standard nutritional counselling and instruction on how to manage symptoms that interfere with patient's appetite and oral intake. Supplements rich in branched-chain amino acids (Inner Power {\circledR} , Otsuka Pharmaceutical Co., Ltd., Japan) were provided. The primary endpoint of the study was feasibility, which was defined as the proportion of patients attending ≥4 of six sessions. Secondary endpoints included compliance and safety. Results: The median patient age was 75 years (range, 70–84). Twelve patients (40{\%}) were cachectic at baseline. Twenty-nine patients attended ≥4 of the six planned sessions (96.7{\%}, 95{\%} confidence interval, 83.3 to 99.4). One patient dropped out due to deteriorating health status. The median proportion of days of compliance with supplement consumption and exercise performance were 99{\%} and 91{\%}, respectively. Adverse events possibly related to the NEXTAC programme were observed in five patients and included muscle pain (Grade 1 in two patients), arthralgia (Grade 1 in one patient), dyspnoea on exertion (Grade 1 in one patient), and plantar aponeurositis (Grade 1 in one patient). Conclusions: The early induction of multimodal interventions showed excellent compliance and safety in elderly patients with newly diagnosed pancreatic and non-small-cell lung cancer receiving concurrent chemotherapy. We are now conducting a randomized phase II study to measure the impact of these interventions on functional prognosis.",
keywords = "Cancer cachexia, Elderly, Multimodal intervention, Non-small-cell lung cancer, Pancreatic cancer, Physical activity",
author = "Tateaki Naito and Shuichi Mitsunaga and Satoru Miura and Noriatsu Tatematsu and Toshimi Inano and Takako Mouri and Tetsuya Tsuji and Takashi Higashiguchi and Akio Inui and Taro Okayama and Teiko Yamaguchi and Ayumu Morikawa and Naoharu Mori and Toshiaki Takahashi and Florian Strasser and Katsuhiro Omae and Keita Mori and Koichi Takayama",
year = "2019",
month = "2",
day = "1",
doi = "10.1002/jcsm.12351",
language = "English",
volume = "10",
pages = "73--83",
journal = "Journal of Cachexia, Sarcopenia and Muscle",
issn = "2190-5991",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer

AU - Naito, Tateaki

AU - Mitsunaga, Shuichi

AU - Miura, Satoru

AU - Tatematsu, Noriatsu

AU - Inano, Toshimi

AU - Mouri, Takako

AU - Tsuji, Tetsuya

AU - Higashiguchi, Takashi

AU - Inui, Akio

AU - Okayama, Taro

AU - Yamaguchi, Teiko

AU - Morikawa, Ayumu

AU - Mori, Naoharu

AU - Takahashi, Toshiaki

AU - Strasser, Florian

AU - Omae, Katsuhiro

AU - Mori, Keita

AU - Takayama, Koichi

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Background: Combinations of exercise and nutritional interventions might improve the functional prognosis for cachectic cancer patients. However, high attrition and poor compliance with interventions limit their efficacy. We aimed to test the feasibility of the early induction of new multimodal interventions specific for elderly patients with advanced cancer Nutrition and Exercise Treatment for Advanced Cancer (NEXTAC) programme. Methods: This was a multicentre prospective single-arm study. We recruited 30 of 46 screened patients aged ≥70 years scheduled to receive first-line chemotherapy for newly diagnosed, advanced pancreatic, or non-small-cell lung cancer. Physical activity was measured using pedometers/accelerometer (Lifecorder ® , Suzuken Co., Ltd., Japan). An 8 week educational intervention comprised three exercise and three nutritional sessions. The exercise interventions combined home-based low-intensity resistance training and counselling to promote physical activity. Nutritional interventions included standard nutritional counselling and instruction on how to manage symptoms that interfere with patient's appetite and oral intake. Supplements rich in branched-chain amino acids (Inner Power ® , Otsuka Pharmaceutical Co., Ltd., Japan) were provided. The primary endpoint of the study was feasibility, which was defined as the proportion of patients attending ≥4 of six sessions. Secondary endpoints included compliance and safety. Results: The median patient age was 75 years (range, 70–84). Twelve patients (40%) were cachectic at baseline. Twenty-nine patients attended ≥4 of the six planned sessions (96.7%, 95% confidence interval, 83.3 to 99.4). One patient dropped out due to deteriorating health status. The median proportion of days of compliance with supplement consumption and exercise performance were 99% and 91%, respectively. Adverse events possibly related to the NEXTAC programme were observed in five patients and included muscle pain (Grade 1 in two patients), arthralgia (Grade 1 in one patient), dyspnoea on exertion (Grade 1 in one patient), and plantar aponeurositis (Grade 1 in one patient). Conclusions: The early induction of multimodal interventions showed excellent compliance and safety in elderly patients with newly diagnosed pancreatic and non-small-cell lung cancer receiving concurrent chemotherapy. We are now conducting a randomized phase II study to measure the impact of these interventions on functional prognosis.

AB - Background: Combinations of exercise and nutritional interventions might improve the functional prognosis for cachectic cancer patients. However, high attrition and poor compliance with interventions limit their efficacy. We aimed to test the feasibility of the early induction of new multimodal interventions specific for elderly patients with advanced cancer Nutrition and Exercise Treatment for Advanced Cancer (NEXTAC) programme. Methods: This was a multicentre prospective single-arm study. We recruited 30 of 46 screened patients aged ≥70 years scheduled to receive first-line chemotherapy for newly diagnosed, advanced pancreatic, or non-small-cell lung cancer. Physical activity was measured using pedometers/accelerometer (Lifecorder ® , Suzuken Co., Ltd., Japan). An 8 week educational intervention comprised three exercise and three nutritional sessions. The exercise interventions combined home-based low-intensity resistance training and counselling to promote physical activity. Nutritional interventions included standard nutritional counselling and instruction on how to manage symptoms that interfere with patient's appetite and oral intake. Supplements rich in branched-chain amino acids (Inner Power ® , Otsuka Pharmaceutical Co., Ltd., Japan) were provided. The primary endpoint of the study was feasibility, which was defined as the proportion of patients attending ≥4 of six sessions. Secondary endpoints included compliance and safety. Results: The median patient age was 75 years (range, 70–84). Twelve patients (40%) were cachectic at baseline. Twenty-nine patients attended ≥4 of the six planned sessions (96.7%, 95% confidence interval, 83.3 to 99.4). One patient dropped out due to deteriorating health status. The median proportion of days of compliance with supplement consumption and exercise performance were 99% and 91%, respectively. Adverse events possibly related to the NEXTAC programme were observed in five patients and included muscle pain (Grade 1 in two patients), arthralgia (Grade 1 in one patient), dyspnoea on exertion (Grade 1 in one patient), and plantar aponeurositis (Grade 1 in one patient). Conclusions: The early induction of multimodal interventions showed excellent compliance and safety in elderly patients with newly diagnosed pancreatic and non-small-cell lung cancer receiving concurrent chemotherapy. We are now conducting a randomized phase II study to measure the impact of these interventions on functional prognosis.

KW - Cancer cachexia

KW - Elderly

KW - Multimodal intervention

KW - Non-small-cell lung cancer

KW - Pancreatic cancer

KW - Physical activity

UR - http://www.scopus.com/inward/record.url?scp=85055282254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055282254&partnerID=8YFLogxK

U2 - 10.1002/jcsm.12351

DO - 10.1002/jcsm.12351

M3 - Article

C2 - 30334618

AN - SCOPUS:85055282254

VL - 10

SP - 73

EP - 83

JO - Journal of Cachexia, Sarcopenia and Muscle

JF - Journal of Cachexia, Sarcopenia and Muscle

SN - 2190-5991

IS - 1

ER -